# Pilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ Leukemia

> **NCT03186118** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Seattle Children's Hospital** · enrollment: 30 (estimated)

## Conditions studied

- CD 19+ Acute Leukemia

## Interventions

- **BIOLOGICAL:** T-cell Antigen Presenting Cells expressing truncated CD19 (T-APC)

## Key facts

- **NCT ID:** NCT03186118
- **Lead sponsor:** Seattle Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-08-04
- **Primary completion:** 2021-09-13
- **Final completion:** 2033-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03186118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03186118, "Pilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ Leukemia". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03186118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*